Tata Memorial HospitalMumbai, Please Select
Disclosures:
2972 - Addition of SBRT and Outcomes in Borderline Resectable Pancreatic Cancer Patients Having Suboptimal Response to Neoadjuvant Chemotherapy
Tuesday, October 1, 202412:45 PM – 2:00 PM ET
3060 - Matched Pair Analysis of Locally Advanced Pancreatic Cancer Patients Treated with Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy (MAPLAP)